Federal award
DMS PHARMACEUTICAL GROUP INC
SPE2D024F0133
Contract
Obligated and Ceiling
- Obligated (net)
- $72,739.94
- Ceiling (potential value, not spending)
- $72,739.94
- Current value
- $72,739.94
- Gross positive obligations
- $73,316.30
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
- Owner company
- DMS Pharmaceutical GroupBasis direct: the recipient is the company's own reviewed UEI.
- Reported parent
- DMS PHARMACEUTICAL GROUP INC · PX72BSBQTKJ3
- Awarding agency
- Department of Defense · sub-agency 97AS · office SPE2D0
- Funding agency
- Department of Defense · sub-agency 97AS
- Product or service (PSC)
- 6505 · DRUGS AND BIOLOGICALS
- Industry (NAICS)
- 325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
- PIID
- SPE2D024F0133
- Parent vehicle (IDV PIID)
- SPE2D021D0004
- Award type code
- C
- Actions
- 2 · Mar 20, 2024 to Dec 17, 2024
- Why it is listed
- reviewed company, $10k or more
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 17, 2024 | FY2025 | P00001 | M | −$576.36 | |
| Mar 20, 2024 | FY2024 | 0 | — | $73,316.30 |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.